-
Investors Watch List: KeyCorp. (NYSE:KEY), Cambrex Corporation. (NYSE:CBM), Amedica Corporation (NASDAQ:AMDA), Teradata Corporation (NYSE:TDC), Pluristem Therapeutics (NASDAQ:PSTI)
On Thursday shares of KeyCorp. (NYSE:KEY) closed at $14.93. Company’s sales growth for last 5 years was -7.60% and EPS growth for next 5 years is recorded as 9.69%. KeyCorp. (NYSE:KEY) declared that Don Kimble, Chief Financial Officer, together with E.J. Burke and Dennis Devine, Co-Presidents of Key Community Bank will present at the Deutsche…
-
Today’s Watch List: Pluristem Therapeutics (NASDAQ:PSTI), Carrols Restaurant Group (NASDAQ:TAST), NetSol Technologies (NASDAQ:NTWK), New York & Company (NYSE:NWY), Derma Sciences (NASDAQ:DSCI)
On Tuesday shares of Pluristem Therapeutics, Inc. (NASDAQ:PSTI) closed at $2.70. Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PLTR), announced that it has been issued Patent No. EP2366775B1, titled “Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy”, by the European Patent Office. This patent addresses use of adherent stromal cells from…
-
Morning Buzz: Sony Corp (ADR) (NYSE:SNE), Pluristem Therapeutics (NASDAQ:PSTI), Domtar Corporation (NYSE:UFS), Schnitzer Steel Industries (NASDAQ:SCHN), Canadian Pacific Railway (NYSE:CP)
On Thursday shares of Sony Corp (ADR) (NYSE:SNE) closed at $26.54. Company’s sales growth for last 5 years was 0.10%. On 18 March, Sony Corp (ADR) (NYSE:SNE) launched its PlayStation Vue Web video service in three cities, targeting customers looking for cheaper alternatives to cable with packages starting at $50. Pluristem Therapeutics, Inc. (NASDAQ:PSTI) in…
-
Top Morning News: Cyanotech Corp. (NASDAQ:CYAN), Exelon Corporation (NYSE:EXC), Boardwalk Pipeline Partners, LP (NYSE:BWP), Pluristem Therapeutics (NASDAQ:PSTI), TriMas Corporation (NASDAQ:TRS)
Cyanotech Corp. (NASDAQ:CYAN) reported a profit of $304,000, or 5 cents per diluted share, for the company’s third fiscal quarter that ended Dec. 31, compared to a profit of $36,000, or 1 cent per diluted share, for the same fiscal quarter the year before. On Thursday shares of Cyanotech Corp. (NASDAQ:CYAN) closed at $8.59. Company’s…
-
Notable Moves: Pluristem Therapeutics (NASDAQ:PSTI), Micron Technology (NASDAQ:MU), Provectus Biopharmaceuticals (NYSEMKT:PVCT), Lennox International (NYSE:LII), TransAtlantic Petroleum (NYSEMKT:TAT)
Pluristem Therapeutics Inc. (NASDAQ:PSTI), announced an important new finding from its Phase I/II clinical trial of PLacental eXpanded (PLX-PAD) cells in the treatment of muscle injury after total hip arthroplasty (THA). Data showed that six months after surgery the magnitude of improvement in muscle force of the contralateral (non-operated) gluteal muscle was approximately 40 times…
-
Stocks Buzz: Pluristem Therapeutics (NASDAQ:PSTI), Chevron Corporation (NYSE:CVX), Mercury Systems (NASDAQ:MRCY), Arthur J Gallagher & Co. (NYSE:AJG), Paylocity Holding (NASDAQ:PCTY)
On January 20, 2015, Lior Raviv, Team Leader of Product Development at Pluristem Therapeutics, Inc. (NASDAQ:PSTI) presented at ECI’s Fourth Annual Scale-Up and Manufacturing of Cell-Based Therapies Conference in San Diego. On Thursday shares of Pluristem Therapeutics, Inc. (NASDAQ:PSTI) closed at $3.68. Chevron Corporation (NYSE:CVX) announced its subsidiary, Chevron U.S.A. Inc., will work with BP…
-
Watch 5 Stocks: Kulicke and Soffa Industries (NASDAQ:KLIC), Noble Corp (NYSE:NE), EMC Corporation (NYSE:EMC), Farmers Capital Bank (NASDAQ:FFKT), Pluristem Therapeutics (NASDAQ:PSTI)
Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) announced results for its first fiscal quarter ended December 27, 2014. Net revenue of $107.4 million. Gross margin of 50.9%. Net income of $7.8 million or $0.10 per share. On Wednesday shares of Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) closed at $15.75. Company’s sales growth for last 5…
-
Big Movers in Focus: Valero Energy Corporation (NYSE:VLO), American Realty Capital Properties (NASDAQ:ARCP), International Game Technology (NYSE:IGT), Pluristem Therapeutics (NASDAQ:PSTI), DexCom (NASDAQ:DXCM)
Valero Energy Corporation (NYSE:VLO) board has approved a 45 percent increase in the refiner’s regular quarterly cash dividend on its common stock. The dividend will increase to 40 cents a share from 27.5 cents a share payable March 3 to holders of record as of the close of business on Feb. 11.On Friday shares of…
-
Biotech Stocks Touched New Lows: VIVUS Inc. (NASDAQ:VVUS), Protalix BioTherapeutics (NYSEMKT:PLX), Pluristem Therapeutics (NASDAQ:PSTI), BIND Therapeutics (NASDAQ:BIND)
VIVUS, Inc. (NASDAQ:VVUS) on 15 December announced that Qsymia is the sole anti-obesity agent listed on the CVS/Caremark Performance Drug List, or PDL. Preferred brand-name medicines are listed on the PDL to help identify products that are clinically appropriate and cost-effective as defined by CVS/Caremark. VIVUS Inc. (NASDAQ:VVUS) in last trading activity decreased -3.38% to…
-
Stocks Swings: Pluristem Therapeutics (NASDAQ:PSTI), Tesla Motors Inc (NASDAQ:TSLA), Alcatel Lucent SA (ADR) (NYSE:ALU), HCC Insurance Holdings (NYSE:HCC), Cal-Maine Foods (NASDAQ:CALM)
On 1 December Pluristem Therapeutics, Inc. (NASDAQ:PSTI) announced it has been granted a patent in Singapore titled “Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy.” Pluristem Therapeutics, Inc. (NASDAQ:PSTI) in last trading activity fell -0.41% to close at $2.45. Company weekly performance is -2.39% while its quarterly performance…